<DOC>
	<DOCNO>NCT02344420</DOCNO>
	<brief_summary>BIOWOMEN study design compare Cardiac Resynchronization Therapy ( CRT ) response rate Heart Failure ( HF ) population equal distribution men woman . Different clinical variable collect ( QRSd , Left Bundle Brunch Block ( LBBB ) , HF etiology… ) compare order demonstrate woman may respond even good men .</brief_summary>
	<brief_title>Clinical Investigation Differences Magnitude CRT Response WOmen Versus MEN</brief_title>
	<detailed_description>Prospective , non-randomized , international , open , multicenter study . Patients comply inclusion exclusion criterion implant BIOTRONIK CRT system . The primary objective study magnitude CRT response measure function increase Left Ventricular Ejection Fraction ( LVEF ) order demonstrate superior CRT response woman . The Secondary main objective : - To study change major clinical variable 12M FU period men woman - To study Left Ventricular End Diastolic Volume ( LVEDV ) Left Ventricular End Systolic Volume ( LVESV ) change men woman CRT response - To study CRT responder value significant gender difference baseline regard presence inter/intra ventricular dyssynchrony , HF etiology ( ischemic versus non-ischemic cardiomyopathy ) , QRS morphology ( LBBB vs. RBBB ) QRSd - Observational assessment key baseline clinical variable relate patient 's CRT response , create possible `` gender specific '' response model . - Study relationship QRSd ( amount dyssynchrony ) CRT response men woman There study specific requirement implantation procedure CRT device ; implantation perform accord routine hospital 's practice . In order obtain equal distribution male female study population enrol site , inclusion perform consecutively ( base normal hospital flow CRT candidate ) , difference enrolment rate gender exceed &gt; 2 site time enrolment phase . The study flowchart consist baseline assessment , implantation/pre-hospital discharge , 2 month Follow Up ( FU ) , 6 month FU , 12 month FU , final study . Special assessment echocardiography ( echo ) , 6 minute walk test Quality Life test ( QOL ) perform baseline , 6 month one year follow-up . 12-lead electrocardiogram ( ECG ) perform baseline . Device testing , ( Serious ) Adverse ( Device ) Events ( ( S ) A ( D ) E ) , change medication collect plan study FUs throughout duration study . A device interrogation outside schedule study FU window need report unscheduled FU . The timing schedule FUs 2 month , 6 month 12 month implantation ( pre-hospital discharge ) time window ± 1 month . All echo image ECGs save sent respective Core Labs . The estimated sample size 494 patient : 247 men 247 woman .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Indication `` De Novo '' implantation CRT device accord ESC Guidelines Understand nature procedure Give write informed consent CRT Device replacement CRT upgrades Permanent / Persistent Atrial Fibrillation Age &lt; 18 year Pregnant breastfeed woman Subjects irreversible brain damage pre exist cerebral disease Subjects acutely de compensate heart failure NYHA Class IV Heart Failure Heart transplantation six month prior enrolment expect within next 3 month . Cardiac surgery 3 month prior enrolment plan within next 3 month . Have life expectancy le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>CRT</keyword>
</DOC>